505-54-4
Applied Filters:
Keyword:'505-54-4'
Showing 1-30 of 34 results for "505-54-4" within Technical Documents
Monoclonal Anti-Catalase antibody produced in mouse (C0979)
monoclonal
clone CAT-505,purified from hybridoma cell culture
Product Number C0979
Product Description
Monoclonal Anti-Catalase (mouse IgG1 isotype) is
derived from the CAT-505 hybridoma produced
XP725 Antibody Number-Lot Number 071M4826
e-f g-h a-b c-d e-f g-h a-b c-d e-f g-h a-b c-d e-f g-h
1.1 1 2 3 4 25 26 27 28 49 50 51 52 73 74 75 76
1.2 5 6 7 8 29 30 31 32
Product Information Sheet - 10822221001
A laboratory
manual, pp 505-506.
4 Rebase The Restriction Enzyme Database:
http://rebase.neb.com
� Ad2 SV40 � X174 M13mp7 pBR322 pBR328 pUC18
14 54 12 3 4 5 4 4
sigma-aldrich.com
Product Information Sheet - P6024
Inc., New York, NY.
Vol.1:23.
54. Wehling, M. et.al. (1987). ACTA
Endocrinologica 116:555-560.
55. Wehling, M. et.al. (1987). Amer.
Jour. of Phys. 252:505-508.
56. Wehling, M. et.al. (1988
Nitrate Spectroquant Test Kits Method 2017
1.01842 500
Table 4: Spectroquant® Test Kits Absorbance Maxima Range
nm
1.
14
76
4
1.
14
56
3
1.
09
71
3
1.
00
61
4
Nitrate Spectroquant Test Kits Equivalency Report 2017
M
et
ho
ds
4
50
0-
N
O
3 (
E
)
H
ac
h
T
N
T
8
36
1.
14
76
4
1.
14
56
3
Protein Tyrosine Phosphatases- Potential Roles in Disease
Fuente-Garcia, M.A., et al., Blood, 9, 2800-2809 (1998).
53. Autschbach, F., et al., Tissue Antigens, 54, 485-498 (1999).
54. Palou, E., et al., Immunol. Lett., 57, 101-103 (1997).
55. Hundt, M. and Schmidt, R.E.
Celltransmissions Newsletter
757 (2002).
34. Lee, R., et al., Cell Signal, 14, 277-284 (2002).
35. Niiya, T., et al., FEBS Lett., 505, 136-140 (2001).
36. Le Jeune, I.R., et al., J. Biol. Chem., 277, 35980-35989 (2002).
37. Torras-Llort
Outstanding performance Purospher®STAR HPLC and UHPLC columns - EMD
. Ethylbenzene; 4. Quinizarin; 5. Amitryptyline
0 2 4 6 8 10 12 14 16 18 20
Retention time [min]
0
5
10
15
20
25
30
35
Intensity [mV]
Brochure: Purospher STAR HPLC and UHPLC Columns
Ethylbenzene;
4. Quinizarin;
5. Amitryptyline
0 2 4 6 8 10 12 14 16 18 20
Retention time [min]
0
5
10
15
20
25
30
35
Intensity [mV]
Calbiochem Biologics 30.2
NO. 15
CORRECTIONS 11.10.04.indd 28CORRECTIONS 11.10.04.indd 28 11/10/04 12:13:54 PM11/10/04 12:13:54 PM
Biologics
Tubulin Polymerization and Depolymerization:
Exploiting the Dynamic
Analyzing Fatty Acids by Capillary Gas Chromatography
Laboratory, 20, 100-105 (1988).
2. Ackman, R.G., Lipids, 2, 502-505 (1967).
3. Woodford, F.P. and C.M. Van Gent, J. Lipid Res., 1, 188 (1960).
4. Miwa, T.K., K.L. Mikolajczak, F.R. Earle, and I.A. Wolf, Anal
ExPlore with Confidence: Prestige Antibodies Breast Cancer Research
N-terminal domain
and mediates its deposition at centromeres. Proc Natl Acad Sci U S A 2010 Jan
26;107(4):1349-54
84. de Tayrac M et al. Prognostic Significance of EDN/RB, HJURP, p60/CAF-1 and PDLI4,
Four New
Article: Prognostic nomogram incorporating neutrophil-to-lymphocyte ratio for early mortality in decompensated liver cirrhosis
no-
mogram for acute-on-chronic hepatitis B liver failure, J. Gastroenterol. Hepatol. 32
(2017) 497–505.
[14] T. Horvatits, A. Drolz, K. Roedl, et al., Serum bile acids as marker for acute de-
compensation
HPLC Reagents
1
25
4
M
X0
48
8
M
et
ha
no
l
54
6.
0.
73
12
.9
1.
32
9
0.
55
33
.6
2.
Fast and reliable - All you need for histology
Excitation filter 490-570 nm
Color separator 525 and 635 nm
Band elimination filter 505-600 nm
Result
Acid-fast bacteria appear red or yellow-green under the
fluorescence microscope
Bioreactor Systems for Bone Tissue Engineering
of pulsed
electromagnetic fields on bone formation and bone loss
during limb lengthening. Bone 18, 505, 1996.
137. Gossling, H.R., Bernstein, R.A., and Abbott, J. Treatment of
ununited tibial fractures
Organic and Molecular Electronics
×10-16s-1)
SBD-1 474 62±3 1.8 3.4 1.2±0.20 0.97
SBD-4 504 92±2 2.2 4.4 9.5±1.0 1.54
BSB-Cz 462 99±1 1.0 10 0.32±0.05 2.70
BSB-Me 505 92±3 1.0 9.1 0.78±0.10 2.66
BSB-OMe 530 90±1 1.2 7.2 0.90
XP725 Antibody List Lot 129K4831
006149.2 y n/d y
497 Neurofibromin N3662 4763 NF1 M NP_000258.1,NP_001035957.1 ,NP_001121619.1 y y y
505 NF-kB N8523 4790 NFKB1 M NP_001158884.1 y y n/d
378 IkBa I0505 4792 NFKBIA P NP_065390.1 y y y
491
XP725 Antibody List Lot 129K4830
006149.2 y n/d y
497 Neurofibromin N3662 4763 NF1 M NP_000258.1,NP_001035957.1 ,NP_001121619.1 y y y
505 NF-kB N8523 4790 NFKB1 M NP_001158884.1 y y n/d
378 IkBa I0505 4792 NFKBIA P NP_065390.1 y y y
491
XP725 Antibody List Lot 089K4791
006149.2 y n/d y
497 Neurofibromin N3662 4763 NF1 M NP_000258.1,NP_001035957.1 ,NP_001121619.1 y y y
505 NF-kB N8523 4790 NFKB1 M NP_001158884.1 y y n/d
378 IkBa I0505 4792 NFKBIA P NP_065390.1 y y y
491
Amplifluor® SNPs HT Genotyping System for FAM-JOE
2000. The use of single-nucleotide polymorphism maps in
pharmacogenomics. Nature Biotechnology 18:505.
6. Nebert, D. 1999. Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical
Amplifluor® SNPs HT Genotyping System for FAM-SR
2000. The use of single-nucleotide polymorphism maps in
pharmacogenomics. Nature Biotechnology 18:505.
6. Nebert, D. 1999. Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical
Amplifluor® SNPs HT Genotyping System for Assay Development
2000. The use of single-nucleotide polymorphism maps in
pharmacogenomics. Nature Biotechnology 18:505.
6. Nebert, D. 1999. Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical
Halal Certificate
ORGANIC (NOP) W232314 A71757 HC-22SI4A51
504. COCOA EXTRACT, BLEND, FG W584649 B65604 HC-22SIUH25
505. COCONUT OIL, VIRGIN, CERTIFIED ORGANIC (NOP) W530155 B15645 HC-22SIZG78
506. COFFEE OIL, ROASTED
Halal Certificate
ORGANIC (NOP) W232314 A71757 HC-23SITK30
504. COCOA EXTRACT, BLEND, FG W584649 B65604 HC-23SIG304
505. COCONUT OIL, VIRGIN, CERTIFIED ORGANIC (NOP) W530155 B15645 HC-23SIWD57
506. COFFEE OIL, ROASTED
Inhibitor Sourcebook 3rd Edition
inhibitor of hEGF-R tyrosine kinase activity (54% inhibition at 10 µM).
10 mg
Bcr-abl Inhibitor 197221 GNF-2; (3-(6)-(4-Trifluoromethoxy-phenylamino)-pyrimidin-4-yl)-benzamide
A cell-permeable and reverisble
List of Antibodies
Neurofilament 68 N5139 M y n/d n/d
503 Neurofilament 160/200 N2912 M y y y
504 Anti Cy3+Cy5 C0992 M NA NA NA
505 NF-κB N8523 M y y n/d
506 NAK (NFκB-Activating Kinase) N2661 M y n/d y
507 NG2 N8912 M n/d n/d
Chrombook 2015 - The world of chromatography in your hands
3. Ethylbenzene
4. Quinizarin
5. Amitriptyline
0 2 4 6 8 10 12 14 16 18 20
Retention time [min]
0
5
10
15
20
25
30
35
Intensity [mV]
1.
54
Brochure: The Supelco® HPLC and UHPLC Column Selection Guide
Ethylbenzene;
4. Quinizarin;
5. Amitryptyline
0 2 4 6 8 10 12 14 16 18 20
Retention time [min]
0
5
10
15
20
25
30
35
Intensity [mV]
Page 1 of 2
Page 1 of 2